Low-level arsenite induced gene expression in HEK293 cells

Area of Science:

• Toxicology
• Molecular Biology
• Genomics

Background:

• Chronic, low-level arsenic exposure is linked to various cancers, particularly kidney cancer.
• Arsenic is primarily excreted by the kidneys, making them a key target organ.
• Arsenite [As(III)] is considered the most toxic form of arsenic at the cellular level.

Purpose of the Study:

• To investigate the impact of low-level arsenite exposure on gene expression in human embryonic kidney cells (HEK293).
• To identify specific genes and cellular pathways affected by realistic arsenite exposure levels.
• To determine if arsenite exposure elicits a dose-dependent and time-dependent response in gene expression.

Main Methods:

• Human embryonic kidney (HEK293) cells were treated with varying concentrations of arsenite [As(III)] (1, 10, 25 microM) for 6 or 24 hours.
• Gene expression profiling was performed using human cDNA microarrays.
• Data analysis involved normalization and identification of genes with significant (2-fold) and reproducible changes in expression.

Main Results:

• Arsenite exposure significantly altered the expression of numerous genes in HEK293 cells.
• 20 genes were up-regulated (e.g., HMOX1, MT1E, FOSL1) and 19 genes were down-regulated (e.g., MYC, JAK1, CENPE).
• Gene expression changes exhibited a dose-dependent trend (1-25 microM) but were not significantly time-dependent (6 vs. 24 h).

Conclusions:

• Low-level arsenite exposure triggers complex cellular responses in kidney cells, including oxidative stress and activation of stress response pathways.
• Affected genes include those involved in stress response, proto-oncogenesis, signaling, and transcription.
• Cellular adaptation to arsenite involves widespread alterations in gene expression, highlighting potential mechanisms of arsenic-induced toxicity and carcinogenesis.